CDC7 as a novel biomarker and druggable target in cancer

Clin Transl Oncol. 2022 Oct;24(10):1856-1864. doi: 10.1007/s12094-022-02853-4. Epub 2022 Jun 3.

Abstract

Due to the bottlenecks encountered in traditional treatment for tumor, more effective drug targets need to be developed. Cell division cycle 7 kinase plays an important role in DNA replication, DNA repair and recombination signaling pathways. In this review, we first describe recent studies on the role of CDC7 in DNA replication in normal human tissues, and then we integrate new evidence focusing on the important role of CDC7 in replication stress tolerance of tumor cells and its impact on the prognosis of clinical oncology patients. Finally, we comb through the CDC7 inhibitors identified in recent studies as a reference for further research in clinical practice.

Keywords: CDC7; CDC7 inhibitors; Cell cycle; Prognosis; Replication stress.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Cell Cycle Proteins*
  • DNA Replication
  • Humans
  • Neoplasms*
  • Protein Serine-Threonine Kinases

Substances

  • Biomarkers
  • Cell Cycle Proteins
  • CDC7 protein, human
  • Protein Serine-Threonine Kinases